Introduction
============

Hantavirus infections are responsible for human disease worldwide with up to 200,000 cases estimated per year. As the only bunyaviruses being carried by small mammals, these zoonotic agents can cause Hemorrhagic Fever with Renal Syndrome (HFRS) or Hantavirus Cardiopulmonary Syndrome (HCPS) with case fatality rates of up to 50% ([@B17], [@B16]).

Sangassou virus as the first autochthonous African hantavirus was found in Guinea, West Africa, in 2006. First serological studies of patients with fever from the area indicated human hantavirus infections implying underestimation of hantavirus public health impact on the African continent ([@B10], [@B11], [@B13]). During the recent years a high number of novel hantaviruses from non-conventional hosts, as shrews, moles, and bats, have been molecularly detected, many of them in Africa (for a review, see [@B26]). The mere existence of these vastly uncharacterized viruses induces speculations about their emergence in further hosts and geographic areas. Particularly in Africa, where many diseases remain neglected or underreported due to bad health care conditions, and other hemorrhagic fever viruses like Lassa or Ebola occur, nearly nothing is known about the epidemiology and case definition of hantavirus disease in humans. The typical clinical symptoms known from hantavirus-infected patients in the Old and New World include high fever, hemorrhages, thrombocytopenia, abdominal pain, flu-like symptoms, and finally organ failure -- symptoms known to be also caused by many other hemorrhagic fever viruses including arena-, filo-, and flaviviruses ([@B14]; [@B5]; [@B20]). Recent outbreaks of zoonotic diseases, like MERS coronavirus on the Arabian Peninsula ([@B3]) or Ebola virus in West Africa ([@B2]), demonstrate a high necessity for intensive studies of highly pathogenic zoonotic viruses in order to be prepared for their emergence and major outbreaks.

Here we investigated the presence of hantavirus antibodies in humans living in the Taï National Park in Côte d'Ivoire as part of the West African Guinean Forest Block and of the Salonga National Park in the Democratic Republic (DR) of Congo as part of the Central African Congo Basin -- two regions where the richest and oldest tropical evergreen rainforest biomes on Earth exist ([@B7]), potentially facilitating close contact and high exposure of the human population to putative hantavirus hosts. So-called bush meat, which includes small mammals such as bats and rodents, is consumed regularly by inhabitants of the villages in scope. It seems obvious that living within or close to a biodiversity hotspot, like a tropical forest, leads to high risk of infection by a variety of infectious agents ([@B27]; [@B9]). While indigenous hantaviruses have already been found in animal samples from Côte d'Ivoire \[Azagny virus ([@B8]), Mouyassué virus ([@B23])\], DR Congo thus far remains a country without proven hantavirus occurrence. Nevertheless, bat species shown to carry hantaviruses elsewhere ([@B23]; [@B25]) naturally occur in the region.

Materials and Methods {#s1}
=====================

Study Sites and Populations
---------------------------

To screen for seropositive individuals, serum samples were collected from 16 villages in Taï National Park of Côte d'Ivoire in 2007 and five villages in Salonga National Park of DR Congo in 2011 (**Figure [1](#F1){ref-type="fig"}**). The investigation was approved by the National Ethics Commissions of both countries and all participants gave their approval prior to the sampling. The sera were frozen directly in the field in liquid nitrogen. Altogether 982 samples were analyzed -- for sample composition according to location, see **Table [1](#T1){ref-type="table"}**. Participants were also asked for professional status to estimate possible virus exposure and for recent health problems.

![**Map of Western/Central Africa showing location of study sites illustrated by circles.** The shaded areas mark tropical rain forest biome. CI, Côte d'Ivoire; DRC, Democratic Republic of Congo.](fmicb-06-00518-g001){#F1}

###### 

Sample composition and proof of antibody-positive sera according to sampling location.

  Village           Country   Seropositives/no. tested
  ----------------- --------- --------------------------
  Daobly            CI        0/34
  Djereoula         CI        0/31
  Djidoubaye        CI        1/38 (2.6%)
  Gahably           CI        0/54
  Goulegui Beoue    CI        1/54 (1.9%)
  Keibly            CI        7/88 (8.0%)
  Ponan             CI        0/18
  Portgentil        CI        1/47 (2.1%)
  Sakre             CI        6/73 (8.2%)
  Sioblooula        CI        3/34 (8.8%)
  Taï               CI        0/26
  Tieleoula         CI        2/36 (5.6%)
  Tienkoula         CI        2/39 (5.5%)
  Zagne             CI        0/12
  Zaipobly          CI        3/35 (8.6%)
  Ziriglo           CI        1/68 (1.5%)
  ***Total CI***              ***27/687 (3.9%)***
  Bekombo           DRC       0/3
  Ipope             DRC       1/57 (1.8%)
  Iyoko             DRC       0/1
  Lompole           DRC       4/134 (3.0%)
  Nganda            DRC       2/100 (2.0%)
  ***Total DRC***             ***7/295 (2.4%)***

CI, Côte d'Ivoire; DRC, Democratic Republic of Congo.

Serological Test Algorithm
--------------------------

The collected sera were analyzed following a serodiagnostic algorithm as described previously ([@B11]; [@B26]). Shortly, a screening enzyme-linked immunosorbent assay (ELISA) was performed using recombinant nucleocapsid antigens from prototypical hantaviruses including Dobrava-Belgrade virus, Puumala virus ([@B21]), and the African Sangassou virus with a serum dilution of 1:200. All positive samples were subsequently tested in an in-house Western Blot (WB) with Sangassou virus antigen and by recomLine HantaPlus strip blot (Mikrogen, Germany) according to manufacturer's specifications with a dilution of 1:100. Finally, an in-house immunofluorescence assay (IFA) with VERO-E6 cells infected with Hantaan, Dobrava-Belgrade, Puumala, or Sangassou viruses was performed. The lowest dilution for IFA was 1:20, followed by titration of samples with sufficient volumes available. Sera positive in all three test formats were considered as hantavirus seropositive. Focus reduction neutralization assay (FRNT) against Dobrava-Belgrade, Puumala, and Sangassou viruses was performed for selected samples, with enough sample material.

Molecular Testing
-----------------

Samples with high absorbance values in ELISA were also tested for hantavirus IgM antibodies and, in case of a positive result, RNA was extracted and screened by pan-hantavirus RT-PCR ([@B10]) to target possible current infections which exhibit RNAemia.

Statistical Analyses
--------------------

The database with serodiagnostic results was established in Excel® for Windows, before being transferred to Stata (Stata/SE12.0 for Windows, Stata Corp, College Station, TX, USA). Seroprevalences were calculated including 95% confidence intervals (CI). The effect of country, sex, age, village, and occupation on the serological status was initially investigated with logistic regression models with serological status as binary dependent variable and the other factors as independent variables.

Results
=======

Samples and Demographic Data
----------------------------

A total of 982 blood samples were analyzed in the study, 687 and 295 samples were collected in Côte d'Ivoire and DR Congo, respectively. The average number of samples per village was 49 (range 1--134). The mean age of the participants was 35 years (range 3--95, *n* = 932). 53% of the participants were females (reported gender, *n* = 953). Occupation data were available for 92% (*n* = 900) of the samples. Most people were occupied with agriculture (40%, *n* = 356) or house work (28%, *n* = 255), 15% (*n* = 134) were pupils and the rest reported the following occupations: teacher/student, sales/business person, cook/restaurant worker, tailor, driver/mechanic, fisherman, builder, hunter/meat seller, and health worker. For sample composition according to profession, age, and gender, see **Table [2](#T2){ref-type="table"}**.

###### 

Seropositive participants from both study sites according to profession, age, and gender in both countries.

  Analysis by       Seropositives/no. tested
  ----------------- --------------------------
  **Profession**    
  Agriculture       14/356 (3.9%)
  House work        9/255 (3.5%)
  Pupils            3/134 (2.2%)
  Teacher/student   0/27
  Sales/business    1/24 (4.2%)
  Cook/restaurant   0/19
  Tailor            1/17 (5.9%)
  Driver/mechanic   0/16
  Fisher            1/16 (6.25%)
  Various           0/15
  Builder           0/9
  Hunter/butcher    0/7
  Healthcare        0/5
  ***Total***       **29/900**
  **Age**           
  1--10             1/38 (2.6%)
  11--20            7/207 (3.4%)
  21--40            14/327 (4.3%)
  41--60            5/226 (2.2%)
  \>60              5/89 (5.6%)
  ***Total***       ***32/932***
  **Gender**        
  Female            19/503 (3.8%)
  Male              15/450 (3.3%)
  ***Total***       ***34/953***

Profession and age were known for 900 and 932 participants, respectively.

Serology and Molecular Testing
------------------------------

The confirmed seroprevalence was 3.9% (27/687; 95% CI 2.6--5.7%) and 2.4% (7/297; 95% CI 1.0--4.8%) for the groups from Côte d'Ivoire and DR Congo, respectively. There was no statistical significant difference between the prevalences in the two countries (*p* \> 0.05). The primary screening ELISA detected 229/982 seropositive samples against Sangassou virus antigen and only 28/982 against Puumala virus antigen. Out of all samples found to be positive in the screening ELISAs, 34 sera were confirmed to be seropositive by all levels of the test algorithm. Thirty out of the 34 seropositive samples were found to be reactive (12 of them even exclusively) against Sangassou virus antigen in the screening ELISA. For detailed results, see Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. For 13/34 of the positive sera, where FRNT was performed, none of the used viruses was neutralized effectively (data not shown).

Considering all samples collected in the study, seropositive individuals were detected in 10/16 villages in Côte d'Ivoire (Djidoubay, Goulegui, Keibly, Portgenti, Sakre, Sioblooula, Tieleoula, Tienkoula, Zaipobly, and Ziriglo) and in 3/5 villages in DR Congo (Ipope, Lompole, and Nganda). The prevalence per village ranged from 0 to 8.8% (see **Table [1](#T1){ref-type="table"}**); there was no statistical difference in prevalence between the villages (*p* \> 0.05). Seropositivity was detected in 19 females and 15 males, in individuals that were between 3 and 81 years old, and in people with the following occupation: agriculture, sales/business persons, pupils, tailors, fishermen, and house workers. There was no statistically significant effect of gender, age, or occupation on serology status (*p*-value for all factors \>0.05). The statistical model explained 8.4% of the variation in the serological status. There was no statistically significant difference between the prevalence in Côte d'Ivoire and DR Congo in any village and for all villages together (*p* \> 0.05).

In comparison to previous studies, the prevalence was significantly higher (*p* = 0.002) in Côte d'Ivoire than reported for Guinea \[1.2% ([@B11]); 8/649; 95% CI 0.5--2.4%\] and South Africa \[1.0% ([@B26]); 14/1442; 95% CI 0.5--1.5%\]. RT-PCR testing of 13 individuals with high IgM values did not reveal any detectable viremia within the study group.

Health Problems within Study Population
---------------------------------------

Self-reported symptoms among the probands included problems common in African villages: 36% of the participants reported at least one type of recent health problem. Most common were malaria (*n* = 127), cough (*n* = 55), back pain (*n* = 47), and abdominal pain (*n* = 37). Four people reported fever. Of the hanta seropositive people four reported malaria, six reported cough, five reported back pain, two reported abdominal pain, and nine reported other symptoms. No hanta positive person reported fever only. Self-reported "malaria" is likely meaning symptoms that include fever. The self-reported medical information was not included into the statistical model due to the large number of different symptoms.

Discussion
==========

Our work shows that people in the two studied African regions carry antibodies against hantavirus, strongly suggesting their previous exposure to this pathogen. For two countries so far not investigated in this matter, seroprevalence rates of 3.9% in Côte d'Ivoire and 2.4% in DR Congo were ascertained. In recent studies performed in Guinea and in South Africa with the same antigens and methodology, seroprevalence rates of 1.2 and 1.0%, respectively, were found in the average populations ([@B11]; [@B26]), while elevated hantavirus seroprevalence (4.4%) could be found among Guinean patients with uncharacterized fever ([@B11], [@B12]). Our study demonstrates a significantly higher seroprevalence of hantavirus antibodies within the major tropical rainforest region of Côte d'Ivoire (but not DR Congo) in comparison to our findings from Guinea or South Africa. This indicates that some populations living in tropical forest regions with their rich biodiversity and high potential for close contact to, e.g., wildlife hosts encounter relatively higher exposure to hantaviruses. While there is molecular evidence for the occurrence of bat- and shrew-associated hantaviruses in Côte d'Ivoire ([@B8]; [@B23]), the association of these particular viruses with the human infections remains, however, to be shown.

About 97% of people above 16 years participating in the study reported consumption of rodents and other small mammals. Professional exposure seemed not to play a statistically significant role within our study group, however, occupations in agriculture and meat preparation, usually having a higher risk for hantavirus infections ([@B22]), made up more than 70% of the probands, not including pupils. Many participants usually helped out in agriculture during harvest season, even if they work somewhere else, or they change occupation frequently. All these influencing variables might contribute to the postulated high exposure.

Among the study group, many people reported a large variety of recent health problems that are common in African villages, mainly malaria (probably meaning fever and headache), cough, back pain, and abdominal pain. On the other hand no serious health problems typical for hantavirus disease with severe course, like hemorrhages or organ failure ([@B17]), were mentioned. Hantavirus-seropositive people did not report more health problems than the rest of the study group. In future studies a specific survey of patients with fever and hemorrhages should be a focal point for an investigation of hantavirus disease within the tropical forest biome.

Assuming a seroprevalence of 3.9 % in the entire population of Côte d'Ivoire and considering the data from Germany \[seroprevalence 1.7% ([@B28]), incidence 3.40 ([@B18])\] and Finland \[seroprevalence 5%, incidence 43.20 ([@B24])\], one could expect the occurrence of up to 7,000 clinical cases/year for an estimated population of \~20 millions.

The immunoassays used in the study exploit the immunodominance of hantavirus nucleocapsid protein ([@B21]) within the infected organism. The use of antigens from African Sangassou virus, but also from Puumala and Dobrava-Belgrade viruses, within our screening increased (due to cross reactivity) the chance of detecting also hantavirus antibodies directed against still uncharacterized, indigenous viruses ([@B1]; [@B19]). The cascade of confirmatory tests was used to exclude false positive results even though it might have decreased the sensitivity. The fact that the primary screening ELISA detected 229/982 samples as positive against Sangassou virus but only 28/982 samples positive against Puumala virus supports the hypothesis of a Sangassou-like virus being the agent responsible for the infections. Finally, the relatively low number of samples positive in all confirmatory assays makes calculations statistically difficult. In future studies the usage of antigens from additional indigenous rodent-, insectivore-, and bat-borne viruses should be forced which is hampered by restricted sequence information for novel African viruses and the complete lack of cell culture isolates of viruses except for Sangassou virus.

In all 13 IgG-positive samples found to be also IgM-positive, no viral RNA was found by RT-PCR techniques. This is not surprising as hantavirus nucleic acid can be usually detected only up to 30 days after infection under good sampling and laboratory conditions ([@B4]; [@B15]), while IgM can last for up to 2 years ([@B21]; [@B6]).

The high proportion of samples positive in Sangassou virus-specific ELISA allows to assume that a close relative could be present in the investigated regions. The fact that six indigenous hantaviruses have been molecularly detected in recent years in Western Africa, together with our results presented here, consolidate this region as a putative hantavirus hotspot. The existence of very diverse hantaviruses hosted by different animal species within the area could lead to the emergence of new variants with high public health impact. We are convinced that more alertness should be paid to possible human hantavirus infections, particularly in the western part of Africa.
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